Mobile-health network launches proprietary AI health companion

SINGAPORE - Mobile-health Network Solutions (NASDAQ:MNDR), a healthcare technology company with $11.6 million in trailing twelve-month revenue, announced Tuesday the launch of Phi GPT, an AI engine developed exclusively for clinical care pathways that powers a health companion named Aiko within the company’s Health Operating System. According to InvestingPro data, the company maintains a strong financial position with more cash than debt on its balance sheet.

Unlike platforms dependent on external AI providers, Aiko operates within MNDR’s closed ecosystem, with core AI developed in-house to minimize reliance on third-party systems. This approach ensures patient queries about medication adherence, preventive measures, and general health remain private and are not shared externally. InvestingPro analysis shows the company is currently trading at a low revenue valuation multiple, with analysts projecting 85% revenue growth for the current fiscal year.

The multilingual companion supports multiple languages across Southeast Asia and other global markets, providing personalized guidance tailored to individual patient needs, including those who are unwell, elderly, or overwhelmed.

"With Phi GPT powering Aiko, we are uniting science and empathy into a single lifelong health companion," said Co-CEO Dr. Siaw Tung Yeng in the press release.

According to early feedback cited by the company, 70 percent of users prioritize empathetic interactions, 65 percent prefer simple interfaces, and 80 percent seek personalized advice.

The company stated that owning and operating Phi GPT reduces costs and improves scalability. MNDR plans to monetize the technology through teleconsult conversion, chronic care subscriptions, pharmaceuticals, diagnostics, future IoT integrations, and selective B2B licensing.

The rollout of Phi GPT began Monday to a limited number of users and will expand to all Singapore users within two weeks and global users within a month, according to the company.

Mobile-health Network Solutions is headquartered in Singapore with operations across Southeast Asia and is expanding into the US market. While the company’s stock has experienced significant pressure, declining over 84% in the past year, InvestingPro analysis suggests the stock is currently undervalued, with additional insights available through the platform’s comprehensive financial health scoring system.

In other recent news, Mobile-health Network Solutions has announced the launch of a $300 million At-the-Market (ATM) equity offering. The funds raised will be used to enhance the company’s AI-driven teleconsultation services, develop advanced large language models for medical case assessment, and build pharmacy delivery infrastructure. Additionally, Mobile-health Network Solutions has entered into a joint venture with Ghana’s Jospong Group to introduce its digital health platform in Ghana, aiming to leverage Jospong’s local expertise and resources. The company also announced a one-for-five reverse stock split of its Class A Ordinary Shares, which will be effective from September 25, 2025. Furthermore, Mobile-health Network Solutions has updated its Insider Trading Policy to introduce a blackout period for trading by directors, officers, and designated insiders around the announcement of material information. The company has also filed materials for an upcoming extraordinary general meeting of shareholders, although specific details about the agenda or date have not been disclosed. These developments reflect Mobile-health Network Solutions’ ongoing efforts to expand its market presence and strengthen its internal governance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.